These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 3548962

  • 1. Phase II study of the combination of carmustine and 6-thioguanine in advanced malignant melanoma.
    Morton RF, Creagan ET, Veeder MH, Elson DL, Laurie JA, Nelimark RA, Chang MN.
    Cancer Treat Rep; 1987 Apr; 71(4):429-30. PubMed ID: 3548962
    [No Abstract] [Full Text] [Related]

  • 2. Phase II study of the combination of vinblastine plus cisplatin administered by continuous 120-hour infusion for patients with advanced malignant melanoma.
    Creagan ET, Ahmann DL, Schutt AJ, Schaid DJ.
    Cancer Treat Rep; 1987 Apr; 71(7-8):769-70. PubMed ID: 3607788
    [No Abstract] [Full Text] [Related]

  • 3. Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma.
    Del Prete SA, Maurer LH, O'Donnell J, Forcier RJ, LeMarbre P.
    Cancer Treat Rep; 1984 Nov; 68(11):1403-5. PubMed ID: 6541973
    [No Abstract] [Full Text] [Related]

  • 4. Dacarbazine, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma: a phase II study.
    Gundersen S.
    Cancer Treat Rep; 1987 Nov; 71(11):997-9. PubMed ID: 3677119
    [No Abstract] [Full Text] [Related]

  • 5. What can we learn from phase II adjuvant trials in melanoma?
    Keilholz U, Suciu S, Eggermont AM.
    Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
    [No Abstract] [Full Text] [Related]

  • 6. Bleomycin, carmustine, vincristine, and dacarbazine in patients with metastatic malignant melanoma.
    Cohen SM, Ohnuma T, Cheung T, Holland JF.
    Cancer Treat Rep; 1983 Oct; 67(10):947-8. PubMed ID: 6194881
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Combination chemotherapy with dacarbazine and vindesine in the treatment of metastatic malignant melanoma.
    Vorobiof DA, Sarli R, Falkson G.
    Cancer Treat Rep; 1986 Jul; 70(7):927-8. PubMed ID: 3719588
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of advanced malignant melanoma with vinblastine, bleomycin, and cisplatin.
    Bajetta E, Rovej R, Buzzoni R, Vaglini M, Bonadonna G.
    Cancer Treat Rep; 1982 Jun; 66(6):1299-302. PubMed ID: 6177408
    [Abstract] [Full Text] [Related]

  • 11. Phase II study of second-line therapy with DTIC, BCNU, cisplatin and tamoxifen (Dartmouth regimen) chemotherapy in patients with malignant melanoma previously treated with dacarbazine.
    Propper DJ, Braybrooke JP, Levitt NC, O'Byrne K, Christodoulos K, Han C, Talbot DC, Ganesan TS, Harris AL.
    Br J Cancer; 2000 Jun; 82(11):1759-63. PubMed ID: 10839287
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cytarabine and cisplatin in advanced malignant melanoma.
    Bajetta E, Verusio C, Bonfante V, Bonadonna G.
    Cancer Treat Rep; 1986 Dec; 70(12):1441-2. PubMed ID: 3791257
    [Abstract] [Full Text] [Related]

  • 14. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
    Tan EH, Ang PT.
    Singapore Med J; 1996 Apr; 37(2):165-7. PubMed ID: 8942255
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapy for metastatic melanoma: effective combination of dacarbazine, carmustine, cisplatin and tamoxifen.
    Fierro MT, Bertero M, Novelli M, Appino A, Doveil GC, Colonna S, Bernengo MG.
    Melanoma Res; 1993 Apr; 3(2):127-31. PubMed ID: 8518551
    [Abstract] [Full Text] [Related]

  • 18. Single-dose dacarbazine and dactinomycin in advanced malignant melanoma.
    Hochster H, Levin M, Speyer J, Dunleavy S, Harris M, Roses D, Golomb F, Muggia F.
    Cancer Treat Rep; 1985 Jan; 69(1):39-42. PubMed ID: 3967259
    [Abstract] [Full Text] [Related]

  • 19. Outpatient chemoimmunotherapy for the treatment of metastatic melanoma.
    Thompson JA, Gold PJ, Fefer A.
    Semin Oncol; 1997 Feb; 24(1 Suppl 4):S44-8. PubMed ID: 9122734
    [Abstract] [Full Text] [Related]

  • 20. [Marked regression of melanoma metastases under combined chemotherapy].
    Klemm-Mayer H, Rasokat H, Wagner G.
    Z Hautkr; 1984 Apr 01; 59(7):443-5. PubMed ID: 6730608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.